Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

81 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Therapeutic drug monitoring in children and adolescents with schizophrenia-spectrum, affective, behavioural, tic and other psychiatric disorders treated with aripiprazole: results of the TDM-VIGIL pharmacovigilance study.
Riegger J, Egberts KM, Clement HW, Schneider-Momm K, Taurines R, Fekete S, Wewetzer C, Karwautz A, Correll CU, Plener PL, Malzahn U, Heuschmann P, Unterecker S, Scherf-Clavel M, Rock H, Antony G, Briegel W, Banaschewski T, Hellenschmidt T, Kaess M, Kölch M, Renner T, Rexroth C, Schulte-Körne G, Walitza S, Gerlach M, Romanos M, Fleischhaker C. Riegger J, et al. Among authors: wewetzer c. J Neural Transm (Vienna). 2024 Nov 2. doi: 10.1007/s00702-024-02819-6. Online ahead of print. J Neural Transm (Vienna). 2024. PMID: 39487894
Therapeutic drug monitoring of children and adolescents treated with aripiprazole: observational results from routine patient care.
Egberts K, Reuter-Dang SY, Fekete S, Kulpok C, Mehler-Wex C, Wewetzer C, Karwautz A, Mitterer M, Holtkamp K, Boege I, Burger R, Romanos M, Gerlach M, Taurines R. Egberts K, et al. Among authors: wewetzer c. J Neural Transm (Vienna). 2020 Dec;127(12):1663-1674. doi: 10.1007/s00702-020-02253-4. Epub 2020 Sep 30. J Neural Transm (Vienna). 2020. PMID: 32997183
Therapeutic drug monitoring of sertraline in children and adolescents: A naturalistic study with insights into the clinical response and treatment of obsessive-compulsive disorder.
Tini E, Smigielski L, Romanos M, Wewetzer C, Karwautz A, Reitzle K, Correll CU, Plener PL, Malzahn U, Heuschmann P, Unterecker S, Scherf-Clavel M, Rock H, Antony G, Briegel W, Fleischhaker C, Banaschewski T, Hellenschmidt T, Imgart H, Kaess M, Kölch M, Renner T, Reuter-Dang SY, Rexroth C, Schulte-Körne G, Theisen F, Fekete S, Taurines R, Gerlach M, Egberts KM, Walitza S. Tini E, et al. Among authors: wewetzer c. Compr Psychiatry. 2022 May;115:152301. doi: 10.1016/j.comppsych.2022.152301. Epub 2022 Feb 26. Compr Psychiatry. 2022. PMID: 35248877 Free article.
Therapeutic drug monitoring in children and adolescents with schizophrenia and other psychotic disorders using risperidone.
Taurines R, Fekete S, Preuss-Wiedenhoff A, Warnke A, Wewetzer C, Plener P, Burger R, Gerlach M, Romanos M, Egberts KM. Taurines R, et al. Among authors: wewetzer c. J Neural Transm (Vienna). 2022 Jun;129(5-6):689-701. doi: 10.1007/s00702-022-02485-6. Epub 2022 Mar 18. J Neural Transm (Vienna). 2022. PMID: 35303169 Free PMC article.
Therapeutic Drug Monitoring in Children and Adolescents: Findings on Fluoxetine from the TDM-VIGIL Trial.
Frey M, Smigielski L, Tini E, Fekete S, Fleischhaker C, Wewetzer C, Karwautz A, Correll CU, Gerlach M, Taurines R, Plener PL, Malzahn U, Kornbichler S, Weninger L, Brockhaus M, Reuter-Dang SY, Reitzle K, Rock H, Imgart H, Heuschmann P, Unterecker S, Briegel W, Banaschewski T, Fegert JM, Hellenschmidt T, Kaess M, Kölch M, Renner T, Rexroth C, Walitza S, Schulte-Körne G, Romanos M, Egberts KM. Frey M, et al. Among authors: wewetzer c. Pharmaceutics. 2023 Aug 25;15(9):2202. doi: 10.3390/pharmaceutics15092202. Pharmaceutics. 2023. PMID: 37765171 Free PMC article.
Transmission disequilibrium studies in children and adolescents with obsessive-compulsive disorders pertaining to polymorphisms of genes of the serotonergic pathway.
Walitza S, Wewetzer C, Gerlach M, Klampfl K, Geller F, Barth N, Hahn F, Herpertz-Dahlmann B, Gössler M, Fleischhaker C, Schulz E, Hebebrand J, Warnke A, Hinney A. Walitza S, et al. Among authors: wewetzer c. J Neural Transm (Vienna). 2004 Jul;111(7):817-25. doi: 10.1007/s00702-004-0134-y. Epub 2004 Apr 13. J Neural Transm (Vienna). 2004. PMID: 15206000
Transmission disequilibrium studies in early onset of obsessive-compulsive disorder for polymorphisms in genes of the dopaminergic system.
Walitza S, Scherag A, Renner TJ, Hinney A, Remschmidt H, Herpertz-Dahlmann B, Schulz E, Schafer H, Lange KW, Wewetzer C, Gerlach M. Walitza S, et al. Among authors: wewetzer c. J Neural Transm (Vienna). 2008 Jul;115(7):1071-8. doi: 10.1007/s00702-008-0051-6. Epub 2008 Apr 30. J Neural Transm (Vienna). 2008. PMID: 18446263
Pilot study on HTR2A promoter polymorphism, -1438G/A (rs6311) and a nearby copy number variation showed association with onset and severity in early onset obsessive-compulsive disorder.
Walitza S, Bové DS, Romanos M, Renner T, Held L, Simons M, Wewetzer C, Fleischhaker C, Remschmidt H, Warnke A, Grünblatt E. Walitza S, et al. Among authors: wewetzer c. J Neural Transm (Vienna). 2012 Apr;119(4):507-15. doi: 10.1007/s00702-011-0699-1. Epub 2011 Aug 28. J Neural Transm (Vienna). 2012. PMID: 21874579
81 results